3-Year Comparison of Sirolimus- Versus Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Artery Disease
JACC: Cardiovascular Interventions · 2026-11
DOI: 10.1016/j.jcin.2026.10.020 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC: Cardiovascular Interventions, 2026-11. Verfasst von Ulf Teichgräber und 31 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany. Electronic address: ulf.teichgraeber@med.uni-je…. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Sirolimus-coated balloons (SCBs) have emerged as alternatives to paclitaxel-coated balloons (PCBs), but randomized comparative data beyond 2 years are lacking. OBJECTIVES: The aim of this study was to compare patient-reported outcomes, effectiveness, and safety through 3 years in symptomatic femoropopliteal artery disease. METHODS: SIRONA was a prospective, multicenter, randomized controlled trial comparing SCB angioplasty with a PCB strategy. Patients were randomized 1:1 after successful predilation. Prespecified 3-year outcomes included walking capacity, health-related quality of life, clinically driven target lesion/vessel revascularization (cdTLR/cdTVR), mortality, major amputation, and amputation-free survival. RESULTS: Among 482 randomized patients (SCB, n = 238; PCB, n = 244), 96.3% had intermittent claudication; 3-year follow-up was completed by 76.5% and 79.6%, respectively. Changes in patient-reported walking distances did not differ between-groups. Three-year freedom from cdTLR was 88.2% (95% CI: 83.1%-91.9%) versus 80.2% (95% CI: 74.1%-85.0%; HR: 0.60, 95% CI: 0.36-0.97; nominal log-rank P = 0.03). Post-hoc analysis suggested time-varying treatment effects (treatment-by-period interaction P = 0.006), with separation after the first year. Freedom from cdTVR (HR: 0.78, 95% CI: 0.50-1.21; nominal P = 0.27) and amputation-free survival (HR: 1.09, 95% CI 0.57-2.09; nominal P = 0.79) did not differ. CONCLUSIONS: Through 3 years, no between-group differences were observed in walking capacity and health-related quality of life or clinical safety outcomes between SCB angioplasty and the PCB strategy. Three-year freedom from cdTLR was higher with SCB angioplasty, with treatment effect that varied over time. Given the exploratory, nonmultiplicity-adjusted 3-year analysis, the cdTLR difference requires confirmation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany. Electronic address: ulf.teichgraeber@med.uni-jena.de.
- Department of Radiology, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.
- Center for Clinical Studies, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.
- Department of Angiology, University Hospital for Internal Medicine II, Medical University Vienna, Vienna, Austria.
- Department of Angiology, University of Leipzig Medical Center, Leipzig, Germany.
- Department of Angiology, University Heart Center Bad Krozingen, University Hospital Freiburg, Bad Krozingen, Germany.
Zitieren
APA
Teichgräber, U., Ingwersen, M., Lehmann, T., Platzer, S., Kunstmann, I., Steiner, S., Schmidt, A., Wittig, T., Zeller, T., Thieme, M., Krankenberg, H., Werner, M., Brodmann, M., Malyar, N., Müller-Hülsbeck, S., de Paoli, L., Schlager, O., Austermann, M., Tepe, G., …, & SIRONA Trial investigators (2026). 3-Year Comparison of Sirolimus- Versus Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Artery Disease. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2026.10.020
Vancouver
Teichgräber U, Ingwersen M, Lehmann T, Platzer S, Kunstmann I, Steiner S, et al. 3-Year Comparison of Sirolimus- Versus Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Artery Disease. JACC: Cardiovascular Interventions. 2026. doi:10.1016/j.jcin.2026.10.020
BibTeX
@article{Teichgrber2026,
author = {Teichgräber, Ulf and Ingwersen, Maja and Lehmann, Thomas and Platzer, Stephanie and Kunstmann, Ina and Steiner, Sabine and Schmidt, Andrej and Wittig, Tim and Zeller, Thomas and Thieme, Marcus and Krankenberg, Hans and Werner, Martin and Brodmann, Marianne and Malyar, Nasser and Müller-Hülsbeck, Stefan and de Paoli, Luca and Schlager, Oliver and Austermann, Martin and Tepe, Gunnar and Erbel, Christian and Ito, Wulf and Waßmer, Rainer and Maiwald, Lars and Aschenbach, René and Wissgott, Christian and Andrassy, Martin and Wolf, Florian and Beschorner, Ulrich and Pech, Maciej and Katsanos, Konstantinos and Scheinert, Dierk and SIRONA Trial investigators, SIRONA Trial investigators},
title = {3-Year Comparison of Sirolimus- Versus Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Artery Disease},
journal = {JACC: Cardiovascular Interventions},
year = {2026},
doi = {10.1016/j.jcin.2026.10.020}
}
EUVIMED